EP Patent

EP3110826A1 — Process for preparing novel forms of tiacumicin b

Assigned to Olon SpA · Expires 2017-01-04 · 9y expired

What this patent protects

The present invention relates to a process for obtaining Tiacumicin B with a well defined crystal habit and particle size. The process according to the invention comprises repeating cycles of heating and cooling under controlled conditions of temperature and stirring.

USPTO Abstract

The present invention relates to a process for obtaining Tiacumicin B with a well defined crystal habit and particle size. The process according to the invention comprises repeating cycles of heating and cooling under controlled conditions of temperature and stirring.

Drugs covered by this patent

Patent Metadata

Patent number
EP3110826A1
Jurisdiction
EP
Classification
—
Expires
2017-01-04
Drug substance claim
No
Drug product claim
No
Assignee
Olon SpA
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.